Target: Salves
Seller: Salves Shareholders
Advisory sell side: LXA | Legal Advisory
Orange Corporate Finance | Financial Advisory
Buyer: Avedon Capital Partners
Advisory buy side: JSA Tax | Tax Advisory
KPMG | Financial Due Dilligence
Orange Clover| Legal Advisory
Date announced: 2022-10-14

Avedon Capital Partners ("Avedon") has invested in Salves, a leading provider of software testing services in the Netherlands. The purpose of the partnership is to accelerate Salves' growth path through organic and selective acquisitions.

Founded in 2006, Salves is a leading provider of software testing services in the Netherlands. With more than 120 experienced consultants, Salves enhances IT quality through a broad range of innovative testing solutions, supporting its clients in achieving their business goals. In addition to consulting services, Salves also provides automated software testing solutions for electronic medical record software. The firm serves medium to large clients in a variety of industries and has extensive expertise in (semi)government and healthcare. Salves' success to date can be attributed to its unique corporate culture with a strong focus on employees and customers.

The partnership will allow Salves to accelerate growth by investing in the organization and taking a buy-and-build approach, further investing in talent and strengthening its service portfolio. Maintaining a unique, intimate company culture is critical along the way.

Source: Mergermarket
Source: MenA
Source: Avedon
Source: Orange Corporate Finance